UHT

UHT
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $25.302M ▲ | $15.494M ▲ | $4.016M ▼ | 15.872% ▼ | $0.29 ▼ | $17.345M ▲ |
| Q2-2025 | $24.868M ▲ | $14.633M ▲ | $4.492M ▼ | 18.063% ▼ | $0.33 ▼ | $16.795M ▼ |
| Q1-2025 | $24.548M ▼ | $14.15M ▲ | $4.777M ▲ | 19.46% ▲ | $0.35 ▲ | $16.871M ▼ |
| Q4-2024 | $24.642M ▲ | $13.995M ▼ | $4.661M ▲ | 18.915% ▲ | $0.34 ▲ | $17.125M ▼ |
| Q3-2024 | $24.494M | $14.618M | $3.997M | 16.318% | $0.29 | $17.137M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $6.916M ▲ | $568.037M ▼ | $409.463M ▲ | $158.574M ▼ |
| Q2-2025 | $6.554M ▼ | $573.016M ▼ | $407.864M ▲ | $165.152M ▼ |
| Q1-2025 | $6.974M ▼ | $573.482M ▼ | $401.316M ▼ | $172.166M ▼ |
| Q4-2024 | $7.097M ▲ | $580.862M ▼ | $401.321M ▼ | $179.541M ▼ |
| Q3-2024 | $6.372M | $584.33M | $402.691M | $181.639M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $4.016M ▼ | $0 ▼ | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▼ |
| Q2-2025 | $4.492M ▼ | $13.685M ▲ | $-8.786M ▼ | $-5.319M ▲ | $-420K ▼ | $13.685M ▲ |
| Q1-2025 | $4.777M ▲ | $11.611M ▼ | $-1.897M ▲ | $-9.837M ▼ | $-123K ▼ | $11.611M ▼ |
| Q4-2024 | $4.661M ▲ | $13.153M ▲ | $-2.712M ▼ | $-9.716M ▼ | $725K ▼ | $13.153M ▲ |
| Q3-2024 | $3.997M | $9.893M | $-1.497M | $-7.601M | $795K | $9.893M |
Revenue by Products
| Product | Q2-2022 | Q3-2022 | Q4-2022 | Q1-2023 |
|---|---|---|---|---|
Product And Service Other | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, UHT looks like a steady, income‑oriented healthcare landlord built around a single, very important tenant relationship. The income statement and cash flows emphasize consistency rather than rapid growth, with predictable rent, modest profit growth, and one clearly unusual earnings year that should not be over‑interpreted. The balance sheet shows a typical REIT profile: significant property assets funded by a mix of debt and equity, with leverage edging up but still supported by stable cash generation. The business model—essential healthcare properties on long‑term, often triple‑net leases—gives UHT a defensive character and resilience through economic cycles. The key opportunities lie in careful expansion, gradual tenant diversification, and incremental operational improvements, while the key risks center on tenant concentration and sensitivity to financing conditions. It is a conservative, stability‑focused story rather than a high‑growth or high‑innovation one.
NEWS
October 27, 2025 · 4:20 PM UTC
UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2025
Read more
October 27, 2025 · 4:16 PM UTC
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2025, INCREASES 2025 FULL YEAR OPERATING RESULTS FORECAST AND ANNOUNCES $1.5 BILLION INCREASE TO STOCK REPURCHASE PROGRAM AUTHORIZATION
Read more
September 15, 2025 · 12:00 PM UTC
Universal Health Services, Inc. Appoints Darren Lehrich as Vice President of Investor Relations
Read more
September 10, 2025 · 5:20 PM UTC
UNIVERSAL HEALTH REALTY INCOME TRUST ANNOUNCES DIVIDEND
Read more
About Universal Health Realty Income Trust
https://www.uhrit.comUniversal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including acute care hospitals, rehabilitation hospitals, sub-acute care facilities, medical/office buildings, free-standing emergency departments and childcare centers.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $25.302M ▲ | $15.494M ▲ | $4.016M ▼ | 15.872% ▼ | $0.29 ▼ | $17.345M ▲ |
| Q2-2025 | $24.868M ▲ | $14.633M ▲ | $4.492M ▼ | 18.063% ▼ | $0.33 ▼ | $16.795M ▼ |
| Q1-2025 | $24.548M ▼ | $14.15M ▲ | $4.777M ▲ | 19.46% ▲ | $0.35 ▲ | $16.871M ▼ |
| Q4-2024 | $24.642M ▲ | $13.995M ▼ | $4.661M ▲ | 18.915% ▲ | $0.34 ▲ | $17.125M ▼ |
| Q3-2024 | $24.494M | $14.618M | $3.997M | 16.318% | $0.29 | $17.137M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $6.916M ▲ | $568.037M ▼ | $409.463M ▲ | $158.574M ▼ |
| Q2-2025 | $6.554M ▼ | $573.016M ▼ | $407.864M ▲ | $165.152M ▼ |
| Q1-2025 | $6.974M ▼ | $573.482M ▼ | $401.316M ▼ | $172.166M ▼ |
| Q4-2024 | $7.097M ▲ | $580.862M ▼ | $401.321M ▼ | $179.541M ▼ |
| Q3-2024 | $6.372M | $584.33M | $402.691M | $181.639M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $4.016M ▼ | $0 ▼ | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▼ |
| Q2-2025 | $4.492M ▼ | $13.685M ▲ | $-8.786M ▼ | $-5.319M ▲ | $-420K ▼ | $13.685M ▲ |
| Q1-2025 | $4.777M ▲ | $11.611M ▼ | $-1.897M ▲ | $-9.837M ▼ | $-123K ▼ | $11.611M ▼ |
| Q4-2024 | $4.661M ▲ | $13.153M ▲ | $-2.712M ▼ | $-9.716M ▼ | $725K ▼ | $13.153M ▲ |
| Q3-2024 | $3.997M | $9.893M | $-1.497M | $-7.601M | $795K | $9.893M |
Revenue by Products
| Product | Q2-2022 | Q3-2022 | Q4-2022 | Q1-2023 |
|---|---|---|---|---|
Product And Service Other | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, UHT looks like a steady, income‑oriented healthcare landlord built around a single, very important tenant relationship. The income statement and cash flows emphasize consistency rather than rapid growth, with predictable rent, modest profit growth, and one clearly unusual earnings year that should not be over‑interpreted. The balance sheet shows a typical REIT profile: significant property assets funded by a mix of debt and equity, with leverage edging up but still supported by stable cash generation. The business model—essential healthcare properties on long‑term, often triple‑net leases—gives UHT a defensive character and resilience through economic cycles. The key opportunities lie in careful expansion, gradual tenant diversification, and incremental operational improvements, while the key risks center on tenant concentration and sensitivity to financing conditions. It is a conservative, stability‑focused story rather than a high‑growth or high‑innovation one.
NEWS
October 27, 2025 · 4:20 PM UTC
UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2025
Read more
October 27, 2025 · 4:16 PM UTC
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2025, INCREASES 2025 FULL YEAR OPERATING RESULTS FORECAST AND ANNOUNCES $1.5 BILLION INCREASE TO STOCK REPURCHASE PROGRAM AUTHORIZATION
Read more
September 15, 2025 · 12:00 PM UTC
Universal Health Services, Inc. Appoints Darren Lehrich as Vice President of Investor Relations
Read more
September 10, 2025 · 5:20 PM UTC
UNIVERSAL HEALTH REALTY INCOME TRUST ANNOUNCES DIVIDEND
Read more

CEO
Alan B. Miller
Compensation Summary
(Year 2023)

CEO
Alan B. Miller
Compensation Summary
(Year 2023)
Ratings Snapshot
Rating : B-
Institutional Ownership

BLACKROCK, INC.
2.266M Shares
$92.111M

BLACKROCK INC.
2.112M Shares
$85.866M

VANGUARD GROUP INC
1.62M Shares
$65.842M

BLACKROCK FUND ADVISORS
713.844K Shares
$29.018M

STATE STREET CORP
597.778K Shares
$24.3M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
460.005K Shares
$18.699M

MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.
360.143K Shares
$14.64M

GEODE CAPITAL MANAGEMENT, LLC
344.215K Shares
$13.992M

BANK OF NEW YORK MELLON CORP
324.721K Shares
$13.2M

RENAISSANCE TECHNOLOGIES LLC
250.21K Shares
$10.171M

DIMENSIONAL FUND ADVISORS LP
188.828K Shares
$7.676M

MORGAN STANLEY
167.731K Shares
$6.818M

AMERIPRISE FINANCIAL INC
158.762K Shares
$6.454M

PROSHARE ADVISORS LLC
154.381K Shares
$6.276M

INVESCO LTD.
135.988K Shares
$5.528M

AQR CAPITAL MANAGEMENT LLC
134.242K Shares
$5.457M

NORTHERN TRUST CORP
132.499K Shares
$5.386M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
125.44K Shares
$5.099M

STIFEL FINANCIAL CORP
95.665K Shares
$3.889M

PARAMETRIC PORTFOLIO ASSOCIATES LLC
91.828K Shares
$3.733M
Summary
Only Showing The Top 20

